During the past decade, PT Prodia StemCell Indonesia conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "PT Prodia StemCell Indonesia" are "Acute Myocardial Infarction" (1 trials), "Ischemic Stroke" (1 trials), "Nasopharyngeal Cancer" (1 trials) and "Polycystic Ovary Syndrome" (1 trials). Many other conditions were trialed in "PT Prodia StemCell Indonesia" in a lesser frequency.

Most popular intervention types in "PT Prodia StemCell Indonesia" are "Biological" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Allo-Dendritic-Secretome Adjuvant Therapy" (1 trials), "Auto-Dendritic Adjuvant Therapy" (1 trials), "Conditioned Medium" (1 trials), "Control" (1 trials) and "Mesenchymal Stem Cells" (1 trials). Other intervention names were less common.

The vast majority of trials in "PT Prodia StemCell Indonesia" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "PT Prodia StemCell Indonesia". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in PT Prodia StemCell Indonesia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in PT Prodia StemCell Indonesia, 4 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".